Literature DB >> 24744438

Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.

Thomas Bachelet1, Lionel Couzi1, Vincent Pitard2, Xavier Sicard2, Claire Rigothier3, Sébastien Lepreux4, Jean-François Moreau5, Jean-Luc Taupin5, Pierre Merville1, Julie Déchanet-Merville6.   

Abstract

Human cytomegalovirus infection in transplant recipients has been associated with adverse renal allograft outcome and with a large γδ T-cell response, but whether both mechanisms are connected is unknown. We previously showed that most expanded circulating cytomegalovirus-responsive γδ T cells express the Fcγ-receptor CD16, suggesting that γδ T cells may participate in allograft lesions mediated by donor-specific antibodies through antibody-dependent cellular cytotoxicity. Here, we show that cytomegalovirus-specific CD16(pos) γδ T cells can perform antibody-dependent cellular cytotoxicity against stromal cells coated with donor-specific antibodies in vitro. In vivo, graft-infiltrating γδ T cells localized in close contact with endothelial cells only in patients who experienced cytomegalovirus infection and were more frequent within peritubular capillaries and glomeruli from antibody-mediated acute rejections than within those from T cell-mediated acute rejections. Finally, a persistently increased percentage of circulating cytomegalovirus-induced γδ T cells correlated inversely with the 1-year eGFR only in kidney recipients with donor-specific antibodies. Collectively, these data support the conclusion that cytomegalovirus-induced γδ T cells are involved in, and may serve as a clinical biomarker of, antibody-mediated lesions of kidney transplants. Moreover, these findings offer a new physiopathologic link between cytomegalovirus infection and allograft dysfunction in recipients with donor-specific antibodies.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24744438      PMCID: PMC4214528          DOI: 10.1681/ASN.2013101052

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  66 in total

1.  Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.

Authors:  T Kataoka; N Shinohara; H Takayama; K Takaku; S Kondo; S Yonehara; K Nagai
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

2.  Significance and implications of capillaritis during acute rejection of kidney allografts.

Authors:  Fernando G Cosio; Donna J Lager; Elizabeth C Lorenz; Hatem Amer; James M Gloor; Mark D Stegall
Journal:  Transplantation       Date:  2010-05-15       Impact factor: 4.939

3.  The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation.

Authors:  Andrea Knight; Alejandro J Madrigal; Sarah Grace; Janani Sivakumaran; Panagiotis Kottaridis; Stephen Mackinnon; Paul J Travers; Mark W Lowdell
Journal:  Blood       Date:  2010-06-24       Impact factor: 22.113

4.  Capillary deposition of C4d complement fragment and early renal graft loss.

Authors:  H E Feucht; H Schneeberger; G Hillebrand; K Burkhardt; M Weiss; G Riethmüller; W Land; E Albert
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

5.  Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.

Authors:  Jodi M Smith; Lawrence Corey; Rachel Bittner; Laura S Finn; Patrick J Healey; Connie L Davis; Ruth A McDonald
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

6.  Implication of gammadelta T cells in the human immune response to cytomegalovirus.

Authors:  J Déchanet; P Merville; A Lim; C Retière; V Pitard; X Lafarge; S Michelson; C Méric; M M Hallet; P Kourilsky; L Potaux; M Bonneville; J F Moreau
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

7.  Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay.

Authors:  Lionel Couzi; Caroline Araujo; Gwendaline Guidicelli; Thomas Bachelet; Karine Moreau; Delphine Morel; Grégoire Robert; Hervé Wallerand; Jean-François Moreau; Jean-Luc Taupin; Pierre Merville
Journal:  Transplantation       Date:  2011-03-15       Impact factor: 4.939

8.  NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.

Authors:  L G Hidalgo; B Sis; J Sellares; P M Campbell; M Mengel; G Einecke; J Chang; P F Halloran
Journal:  Am J Transplant       Date:  2010-08       Impact factor: 8.086

9.  Cell adhesion markers are expressed by a stable human endothelial cell line transformed by the SV40 large T antigen under vimentin promoter control.

Authors:  P Vicart; P Testut; B Schwartz; C Llorens-Cortes; J J Perdomo; D Paulin
Journal:  J Cell Physiol       Date:  1993-10       Impact factor: 6.384

10.  Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients.

Authors:  C Pouteil-Noble; R Ecochard; G Landrivon; A Donia-Maged; J C Tardy; S Bosshard; S Colon; H Betuel; M Aymard; J L Touraine
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

View more
  13 in total

1.  Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.

Authors:  Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 2.  Tissue-Resident Lymphocytes in the Kidney.

Authors:  Jan-Eric Turner; Martina Becker; Hans-Willi Mittrücker; Ulf Panzer
Journal:  J Am Soc Nephrol       Date:  2017-11-01       Impact factor: 10.121

Review 3.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

4.  Deciphering the Contribution of γδ T Cells to Outcomes in Transplantation.

Authors:  Oliver McCallion; Joanna Hester; Fadi Issa
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

Review 5.  Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.

Authors:  Lionel Couzi; Vincent Pitard; Jean-François Moreau; Pierre Merville; Julie Déchanet-Merville
Journal:  Front Immunol       Date:  2015-01-21       Impact factor: 7.561

Review 6.  Recent advances in renal transplantation: antibody-mediated rejection takes center stage.

Authors:  Eric Pouliquen; Alice Koenig; Chien Chia Chen; Antoine Sicard; Maud Rabeyrin; Emmanuel Morelon; Valérie Dubois; Olivier Thaunat
Journal:  F1000Prime Rep       Date:  2015-05-12

Review 7.  Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation.

Authors:  Miguel López-Botet; Carlos Vilches; Dolores Redondo-Pachón; Aura Muntasell; Aldi Pupuleku; José Yélamos; Julio Pascual; Marta Crespo
Journal:  Front Immunol       Date:  2017-02-16       Impact factor: 7.561

Review 8.  Revisiting the Role of γδ T Cells in Anti-CMV Immune Response after Transplantation.

Authors:  Ahmed Gaballa; Faisal Alagrafi; Michael Uhlin; Arwen Stikvoort
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

9.  Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies.

Authors:  Tristan Legris; Christophe Picard; Dilyana Todorova; Luc Lyonnet; Cathy Laporte; Chloé Dumoulin; Corinne Nicolino-Brunet; Laurent Daniel; Anderson Loundou; Sophie Morange; Stanislas Bataille; Henri Vacher-Coponat; Valérie Moal; Yvon Berland; Francoise Dignat-George; Stéphane Burtey; Pascale Paul
Journal:  Front Immunol       Date:  2016-08-11       Impact factor: 7.561

Review 10.  Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.

Authors:  Nicolle H R Litjens; Lotte van der Wagen; Jurgen Kuball; Jaap Kwekkeboom
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.